CD19 and neoplasm: Upon the activation by CD19+ tumor cells, CD19.CAR-T cells extensively proliferated and reached an expansion peak on day 5 in both simultaneous (Figures 6A, B) and subsequent treatment schedule (Figures 7A, B).